Activated protein C anticoagulant system dysfunction and thrombophilia in Asia

Annals of Laboratory Medicine

Volumn 33, Issue 1, 2013, Pages 8-13

  Hamasaki, Naotaka ^a   Kuma, Hiroyuki ^a   Tsuda, Hiroko ^b  

^a NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

^b NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

Activated protein C anticoagulant system; Asian thrombophilia; Deep vein thrombosis; Protein S; Quantitative assay of protein S; Venous thromboembolism

Indexed keywords

EID: 84872103870     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2013.33.1.8     Document Type: Review

References (62)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996;76: 651-62.
2. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part 2. Thromb Haemost 1996;76: 824-34.
3. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8. (Pubitemid 23053939)
4. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503-6. (Pubitemid 23362165)
5. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7. (Pubitemid 24144355)
6. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
7. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol 1997;34:171-87.
8. Castoldi E and Rosing J. APC resistance: biological basis and acquired influences. J Thromb Haemost 2010;8:445-53.
9. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
10. Franco RF and Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001;109:369-84.
11. Bounameaux H and Rosendaal FR. Venous thromboembolism: Why does ethnicity matter? Circulation 2011;123:2189-91.
12. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
13. Seki T, Okayama H, Kumagai T, Kumasaka N, Sakuma M, Isoyama S, et al. Arg506Gln mutation of the coagulation factor V gene not detected in Japanese pulmonary thromboembolism. Heart Vessels 1998;13:195-8. (Pubitemid 29322462)
14. Isshiki I, Murata M, Watanabe R, Matsubara Y, Kawano K, Aoki N, et al. Frequencies of prothrombin 20210 GA mutation may be different among races-studies on Japanese populations with various forms of thrombotic disorders and healthy subjects. Blood Coagul Fibrinolysis 1998;9:105-6.
15. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res 1997;87:377-85.
16. Kim YW, Yoon KY, Park S, Shim YS, Cho HI, Park SS. Absence of factor V Leiden mutation in Koreans. Thromb Res 1997;86:181-2.
17. Tang L, Guo T, Yang R, Mei H, Wang H, Lu X, et al. Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population. PLoS One 2012; 7:e35773.
18. Kinoshita S, Iida H, Inoue S, Watanabe K, Kurihara M, Wada Y, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 2005;38:908-15.
19. Liu HW, Kwong YL, Bourke C, Lam CK, Lie AK, Wei D, et al. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost 1994;71:416-9. (Pubitemid 24100663)
20. Tsuda H, Hattori S, Tanabe S, Iida H, Nakahara M, Nishioka S, et al. Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality. Ann Clin Biochem 1999;36:423-32.
21. Miyata T, Hamasaki N, Wada H, Kojima T. More on: racial differences in venous thromboembolism. J Thromb Haemost 2012;10:319-20.
22. Trujillo-Santos AJ, Jiménez-Puente A, Perea-Milla E. Association between long travel and venous thromboembolic disease: a systematic review and meta-Analysis of case-control studies. Ann Hematol 2008;87: 79-86.
23. House of Commons Health Committee, The prevention of venous thromboembolism in hospitalised patients (Second report of session 2004-2005). http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/99/99.pdf. (Updated on Mar 2005).
24. Bhatia V, AroraP, Parida AK, Mittal A, Pandey AK, Kaul U. Air travel and pulmonary embolism: "economy class syndrome". J Assoc Physicians India 2009;57:412-4.
25. Ueda S, Hanzawa K, Shibata M, Suzuki S. High prevalence of deep vein thrombosis in tsunami-flooded shelters established after the great East-Japan earthquake. Tohoku J Exp Med 2012;227:199-202.
26. Shigekiyo T, Uno Y, Kawauchi S, Saito S, Hondo H, Nishioka J, et al. Protein S Tokushima: an abnormal protein S found in a Japanese family with thrombosis. Thromb Haemost 1993;70:244-6. (Pubitemid 23222476)
27. Yamazaki Y, Sugiura I, Matsushita T, Kojima T, Kagami K, Takamatsu J, et al. A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene. Thromb Res 1993;70:395-403.
28. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 1994;83: 683-90.
29. Tsuda H, Urata M, Tsuda T, Wakiyama M, Iida H, Nakahara M, et al. Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S. Thromb Res 2002;105:233-9. (Pubitemid 34260946)
30. Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood 2006;107:1737-8. (Pubitemid 43242422)
31. Ikejiri M, Wada H, Sakamoto Y, Ito N, Nishioka J, Nakatani K, et al. The association of protein S Tokushima-K196E with a risk of deep vein thrombosis. Int J Hematol 2010;92:302-5.
32. Hamasaki N. Japanese thrombophilia: Protein S/Protein C anomaly as the major risk factor for Japanese thrombophilia. Jpn J Thromb Hemost 2006;17:136-43 (in Japanese).
33. Tatewaki H, Iida H, Nakahara M, Tsuda H, Kinoshita S, Kanaji T, et al. A novel splice acceptor site mutation which produces multiple splicing abnormalities resulting in protein S deficiency type I. Thromb Haemost 1999;82:65-71.
34. Nakahara M, Iida H, Urata M, Fujise M, Wakiyama M, Kinoshita S, et al. A novel splice acceptor site mutation of protein S gene in affected individuals with type I protein S deficiency: allelic exclusion of the mutant gene. Thromb Res 2001;101:387-93.
35. Iida H, Nakahara M, Komori K, Fujise M, Wakiyama M, Urata M, et al. Failure in the detection of aberrant mRNA from the heterozygotic splice site mutant allele for protein S in a patient with protein S deficiency. Thromb Res 2001;102:187-96.
36. Tsuda H, Tokunaga F, Nagamitsu H, Koide T. Characterization of endoplasmic reticulum-Associated degradation of a protein S mutant identified in a family of quantitative protein S deficiency. Thromb Res 2006; 117:323-31.
37. Yamazaki T, Hamaguchi M, Katsumi A, Kagami K, Kojima T, Takamatsu J, et al. A quantitative protein S deficiency associated with a novel nonsense mutation and markedly reduced levels of mutated mRNA. Thromb Haemost 1995;74:590-5.
38. Yamazaki T, Katsumi A, Kagami K, Okamoto Y, Sugiura I, Hamaguchi M, et al. Molecular basis of a hereditary type I protein S deficiency caused by a substitution of Cys for Arg474. Blood 1996;87:4643-50.
39. Okamoto Y, Yamazaki T, Katsumi A, Kojima T, Takamatsu J, Nishida M, et al. A novel nonsense mutation associated with an exon skipping in a patient with hereditary protein S deficiency type I. Thromb Haemost 1996;75:877-82.
40. Yamazaki T, Katsumi A, Okamoto Y, Takafuta T, Tsuzuki S, Kagami K, et al. Two distinct novel splice site mutations in a compound heterozygous patient with protein S deficiency. Thromb Haemost 1997;77:14-20.
41. Fujimura H, Kambayashi J, Kato H, Sakon M, Kawasaki T, Ariyoshi H, et al. Three novel missense mutations in unrelated Japanese patients with type I and type II protein S deficiency and venous thrombosis. Thromb Res 1998;89:151-60.
42. Iwaki T, Mastushita T, Kobayashi T, Yamamoto Y, Nomura Y, Kagami K, et al. DNA sequence analysis of protein S deficiency-identification of four point mutations in twelve Japanese subjects. Semin Thromb Hemost 2001;27:155-60.
43. Yamazaki T, Saito H, Dahlbäck B. Rapid intracellular degradation of a truncated mutant protein S (Q522X). Thromb Haemost 2002;87:171-2. (Pubitemid 34092595)
44. Hirose M, Kimura F, Wang HQ, Takebayashi K, Kobayashi M, Nakanishi K, et al. Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy. J Thromb Thrombolysis 2002;13:85-8.
45. Okada H, Takagi A, Murate T, Adachi T, Yamamoto K, Matsushita T, et al. Identification of protein Sα gene mutations including four novel mutations in eight unrelated patients with protein S deficiency. Br J Haematol 2004;126:219-25.
46. Okada H, Yamazaki T, Takagi A, Murate T, Yamamoto K, Takamatsu J, et al. In vitro characterization of missense mutations associated with quantitative protein S deficiency. J Thromb Haemost 2006;4:2003-9. (Pubitemid 44226781)
47. Mizukami K, Nakabayashi T, Naitoh S, Takeda M, Tarumi T, Mizoguchi I, et al. One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis. Am J Hematol 2006;81:787-97.
48. Sanada N, Fujimori Y, Kashiwagi T, Takagi A, Murate T, Mizutani E, et al. An Sp1 binding site mutation of the PROS1 promoter in a patient with protein S deficiency. Br J Haematol 2007;138:663-5. (Pubitemid 47206712)
49. Hamasaki N and Kanaji T. Clinical role of protein S deficiency in Asian population. In: Tanaka K, Davie EW, eds. Recent advances in thrombosis and hemostasis. Japan: Springer, 2008:597-613.
50. Bonthron D and Orkin SH. The human von Willebrand factor gene. Structure of the 5' region. Eur J Biochem 1988;171:51-7. (Pubitemid 18042874)
51. Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM, et al. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991;30:253-69.
52. Johansson AM, Hillarp A, Säll T, Zöller B, Dahlbäck B, Halldén C. Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency. Thromb Haemost 2005;94:951-7. (Pubitemid 41645933)
53. Lind-Halldén C, Dahlen A, Hillarp A, Zöller B, Dahlbäck B, Halldén C. Small and large PROS1 deletions but no other types of rearrangements detected in patients with protein S deficiency. Thromb Haemost 2012; 108:94-100.
54. Hamasaki N. Unmasking Asian thrombophilia: is APC dysfunction the real culprit? J Thromb Haemost 2012;10:2016-8.
55. Kimura R, Sakata T, Kokubo Y, Okamoto A, Tomoike H, Miyata T. Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers. J Thromb Haemost 2006;4:2010-3. (Pubitemid 44226782)
56. Tsuda T, Jin X, Tsuda H, Ieko M, Morishita E, Adachi T, et al. New quantitative total protein S-Assay system for diagnosing of protein S type II deficiency: clinical application of the screening system for protein S type II deficiency. Blood Coagul Fibrinolysis 2012;23:56-63.
57. Suzuki A, Sanda N, Miyawaki Y, Fujimori Y, Yamada T, Takagi A, et al. Down-regulation of PROS1 gene expression by 17β-estradiol via estrogen receptor α (ERα)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J Biol Chem 2010;285: 13444-53.
58. Drakenberg T, Ghasriani H, Thulin E, Thämlitz AM, Muranyi A, Annila A, et al. Solution structure of the Ca2+-Binding EGF3-4 pair from vitamin K-dependent protein S: identification of an unusual fold in EGF3. Biochemistry 2005;44:8782-9. (Pubitemid 40840443)
59. Schwede T, Kopp J, Guex N, Peitsch, MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003;31:3381-5. (Pubitemid 37442164)
60. Huang M, Furie BC, Furie B. Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody. J Biol Chem 2004;279:14338-46.
61. Groebke Zbinden K, Banner DW, Ackermann J, D'Arcy A, Kirchhofer D, Ji YH, et al. Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors. Bioorg Med Chem Lett 2005;15:817-22.
62. Sasaki T, Knyazev PG, Cheburkin Y, Göhring W, Tisi D, Ullrich A, et al. Crystal structure of a C-Terminal fragment of growth arrest-specific protein Gas6. Receptor tyrosine kinase activation by laminin G-like domains. J Biol Chem 2002;277:44164-70.